Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Visilizumab (Anti-CD3) For research use only.
Not for use in humans.

Visilizumab (Anti-CD3)

Synonyms:

Visilizumab (Anti-CD3) is a humanized, non-Fc receptor (FcR)-binding IgG2 monoclonal antibody (MoAb) directed against CD3 with potential immunosuppressive activity. Visilizumab has the potential to be used for ulcerative colitis and Crohn's disease research. MW : 144.62 KD.

Visilizumab (Anti-CD3)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Visilizumab (Anti-CD3) is a humanized, non-Fc receptor (FcR)-binding IgG2 monoclonal antibody (MoAb) directed against CD3 with potential immunosuppressive activity. Visilizumab has the potential to be used for ulcerative colitis and Crohn's disease research. MW : 144.62 KD.

Product Details

CAS No. 219716-33-3
Molecular Weight 144.62
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Visilizumab (Anti-CD3) | Visilizumab (Anti-CD3) supplier | purchase Visilizumab (Anti-CD3) | Visilizumab (Anti-CD3) cost | Visilizumab (Anti-CD3) manufacturer | order Visilizumab (Anti-CD3) | Visilizumab (Anti-CD3) distributor